ASCRS Members-Only Webinars

ASCRS webinars are for member surgeons who are interested in learning more about topics related to colorectal diseases, treatment and surgery. The webinars are presented live by subject matter experts and are complimentary as part of your ASCRS membership. Enjoy interaction with the presenters in a live format or view the entire webinar after the event on your schedule.

These brief, yet extremely informative, web-based education sessions are accessible after the event through CREST®.

Accreditation

The American Society of Colon and Rectal Surgeons (ASCRS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of this CME activity.

Upcoming Webinar

_Webinar-Sub-ASCRS-Deconstructed.jpg

ASCRS Deconstructed

Wednesday, March 4, 2020, 7:00 pm Central Time
Moderator: 
Heather Yeo, MD, MHS
Speakers: David Westman, Neil Hyman, MD; Arden Morris, MD, MPH; and Jason Mizell, MD

Register Now

ASCRS has a long history of building leaders in colon and rectal surgery. This webinar will briefly cover that history, as well as the growth of the society and how to be involved as the society moves forward. This webinar will offer advice from all levels—from the Executive Council to the young surgeons—about how the society, board and research foundation work and their leadership structure. Early and mid-career surgeons will gain an understanding of the benefits of being involved in the society, how to be involved and how to make their way up the ladder.

Heather Yeo   Heather Yeo, MD, MHS, is the vice chair of the ASCRS Social Media Committee. She has a master’s in health services research and is focused on surgical outcomes and quality improvement in gastrointestinal cancer surgery. She has been working with Cornell Tech to develop mobile apps to track patients in the perioperative period. Dr. Yeo
 
Westman-Profile-Picture.jpg   David Westman, CAE is the ASCRS executive director. He is both a Certified Public Accountant (CPA) and a Certified Association Executive (CAE). The American Society of Association Executives published a book written by him in 2016, “Board and CEO Roles for Association Goals,” which addresses best leadership practices in associations. In 2013 received the Association Forum’s Inspiring Leader of the Year award.
Hyman,-Neil-2018.jpg   Neil Hyman, MD, is the ASCRS president-elect. He is currently a professor of surgery, chief of the Section of Colon and Rectal Surgery and co-director of the Center for Digestive Diseases at the University of Chicago Medicine. He has authored more than 225 peer-reviewed original articles and textbook chapters.
Arden Morris   Arden M. Morris, MD, MPH, is a member-at-large on the ASCRS Executive Council and chair of the ASCRS Committee on Committees. She also serves as the vice chair on the Commission on Cancer’s National Accreditation Program for Rectal Cancer Quality Committee. She is a professor of surgery and vice chair for research in the Stanford Department of Surgery.
Jason Mizell   Jason Mizell, MD, recently completed his stint as chair of the ASCRS Young Surgeons Committee, where he developed the society’s first Mock Oral Examination workshop for Fellows and the Financial Planning for the Colorectal Surgeon symposium. He is an associate professor of surgery at the University of Arkansas for Medical Sciences, where he is the program director of the Transition Year Program.

Archived Webinars

Pilonidal Disease

Original webinar date: February 11, 2020, 7:00 pm CT

Moderator: Eric K. Johnson, MD, FACS, FASCRS
Speakers: David Rosen, MD; Muneera R. Kapadia, MD, MME, FACS, FASCRS

Pilonidal disease is a common ailment seen by colorectal and general surgeons all over the world. Despite the common nature of the disease, its treatment is associated with complications and recurrence. Many surgeons lack awareness of some of the more modern flap-based procedures that can lead to a lower recurrence rate. It is imperative to disseminate this information in a meaningful and easy-to-access forum, such that patient outcomes can be optimized. Various operative techniques can be reviewed and tips and tricks can be discussed. A question- and answer-based portion facilitated adequate attention to issues facing surgeons who treat this disease. A case-based discussion similarly assisted with proper technique selection.

Learning Objectives:

  • Describe both basic operative and non-operative management of pilonidal disease.
  • Describe the pitfalls of surgical management of pilonidal disease.
  • Describe basic postoperative management of surgical patients.
  • Select a surgical procedure most appropriate to the level of disease in a given patient.

Johnson,-Eric-(1).jpgEric K. Johnson, MD, FACS, FASCRS received his BS degree in biology from the University of Maryland at College Park and went on to medical school at the University of Maryland School of Medicine in Baltimore. From there he completed general surgery residency in the US Army and a colorectal fellowship at the Georgia Colon and Rectal Surgical Clinic in Atlanta, GA. He now practices in Cleveland, OH at the Cleveland Clinic. He has written several book chapters on the management of pilonidal disease and has similarly published in peer reviewed journals. He has experience with both simple and complex pilonidal disease and has used the cleft lift and rhomboid flap techniques extensively.

Holubar,-Stefan.jpg

David Rosen, MD, received his AB from Princeton University and his MD from Tufts University School of Medicine prior to completing a residency in general surgery as well as fellowship in surgical critical care at the University of Southern California. Dr. Rosen then completed fellowship in colon and rectal surgery at Washington University in St. Louis. He is currently a staff surgeon in the Department of Colon and Rectal Surgery at the Cleveland Clinic Foundation in Cleveland, Ohio.

Kapadia,-Muneera.JPG

Muneera R. Kapadia, MD, MME, FACS, FASCRS, has a BS in Chemical Engineering from MIT and earned her MD from the University of Michigan. She completed her general surgery training at Northwestern University and a fellowship in colon and rectal surgery at the University of Minnesota. Her clinical practice is broadly based in colon and rectal surgery, with special interests in inflammatory bowel disease and colorectal cancer. Her academic interests are in education-related activities. In addition to completing a Masters in Medical Education, she is Associate Program Director for the General Surgery Residency Program at the University of Iowa and heavily involved in teaching the preclinical medical students.


Behind Every Great Leader is a Great Mentor

Original webinar date: November 14, 2019 7:00pm CT

Moderator: Tracy Hull, MD; ASCRS President
Panelists: Ann Lowry, MD; Daniel Popowich, MD; David Rothenberger, MD; and Patricia Sylla, MDz

Watch the webinar recording. 
This webinar is not eligible for CME.

Mentors can play a vital role in a young surgeon’s career and leadership development. The mentor/mentee relationship can be the most important relationship of an emerging leader’s career. This panel addresses some of the biggest questions surrounding establishing a mentorship connection such as: What makes a great mentor? What makes a great mentee? How do you choose a mentor? When is the right time to seek a mentor? Is there a difference between a sponsor and a mentor? What do you do if it is not a good fit? Do leaders need mentoring? These questions and more are answered in this webinar.


Complex Anorectal Crohn's Disease

Original webinar date: August 15, 2019

Moderator: Daniel Popowich, MD
Speakers: Anjali Kumar MD, MPH, FACS, FASCRS and Elizabeth Breen, MD

This webinar is designed to help you understand the medical and surgical management of simple and comlex perianal Crohn's disease. This includes the medical and surgical management and when to divert. 

Upon completion of this webinar, you should be able to:

  • Understand optimal medical management of perianal Crohn's disease
  • Review local surgical options in the management of perianal Crohn's disease
  • Describe when to divert, temporary or permanantly

The following have no relevant financial relationships to disclose:
Daniel Popowich, MD
Anjali Kumar MD, MPH, FACS, FASCRS
Elizabeth Breen, MD


Rectal Prolapse

Original webinar date: May 16, 2019

Moderator: Brooke Gurland, MD
Speakers: Mehraneh Jafari, MD and Rocco Ricciardi, MD, MPH

Get the webinar recording.
Please log in to your member account before clicking this link. 

Rectal prolapse is a relatively common debilitating condition with both functional and anatomic sequelae.

Rectal prolapse can occur in all age groups as a result of functional bowel and pelvic floor disorders.

Throughout the past century, more than 100 different surgical procedures have been described and there is no consensus regarding the best technique. Recurrence rates for complete rectal prolapse have been reported as high as 20-50 percent. The ideal surgical approach to treat these recurrences remains an unresolved problem.

The goal of this webinar is to discuss the evaluation, workup surgical management and outcomes of rectal prolapse in different subgroups of patients.

Upon completion of this webinar, you should be able to:

  •  Describe the testing needed to assess patients with rectal prolapse prior to surgery
  •  Review the surgical decision making for different subgroups of patients with rectal   prolapse
  •  Review the surgical outcomes for patients undergoing different surgical procedures   for rectal prolapse

The following have no relevant financial relationships to disclose:
Brooke Gurland, MD
Mehraneh Jafari, MD
Rocco Ricciardi, MD, MPH


Surgical Treatment of IBD in the Era of Biologics: Ileal Pouches and Pouchitis

Original webinar date: November 8, 2018

Moderator: Walter A. Koltun, MD, FACS, FASCRS
Speakers: Samuel Eisenstein, MD and Matthew Mutch, MD

Get the webinar recording.
Please log in to your member account before clicking this link. 

There continues to be controversy regarding the surgical treatment of ulcerative colitis, even more so in this era of biologic therapy.  Patients failing medical management will still be treated with colectomy, but now will commonly go to the OR with some biologic agent having been given. Data looking at complications and outcomes associated with surgery and biologic use is difficult to interpret due to the preselected nature of this group of patients, their variable degree of wellbeing at the time of surgery, the variable phenotype of the illness itself and a multitude of differing biologics now being used. However, with time and increasing experience an evolving consensus is emerging, especially insofar as patients undergoing the IPAA procedure. Surgeons need to be aware of factors that can improve or worsen surgical complications associated with the IPAA procedure in patients treated with biologics.

Once the patient undergoes definitive IPAA reconstruction, too often the enigmatic complication of pouchitis will occur. Depending on study and duration of follow up, up to 50% of patients will suffer the signs and symptoms of pouchitis within two years of IPAA creation. Pouchitis suggests itself to be (like IBD) the consequence of the combined effects of genetic predisposition and noxious enteric agents but is very much more responsive to medications, especially antibiotics than the original ulcerative colitis. However, there is, like IBD, a spectrum of pouchitis severity that demands a measured approach with differing therapies based on the specifics of presentation. Though antibiotics may work on mild pouchitis, more severe forms require more aggressive therapy including possibly biologic therapy. The surgeon should be aware of the varying forms and causes of pouchitis, to then be able to institute the appropriate therapy. 

Upon completion of this webinar, participants should be able to:

  • explain the risks and complications associated with IPAA surgery in patients with biologic therapy.
  • identify methods/techniques to modify/improve risk of IPAA surgery in patients on biologic surgery.
  • describe the workup and subclassification of patients with pouchitis.
  • distinguish the various therapies for patients with pouchitis based on subclassification.

The following have no relevant financial relationships to disclose:

Samuel Eisenstein, MD
Walter A. Koltun, MD, FACS, FASCRS
Matthew Mutch, MD


Enhancing Patient-Physician Communications

Original webinar date: February 21, 2019

Moderator:Jennifer S. Beaty, MD, FACS, FASCRS
Speakers: William C. Cirocco, MD and James Merlino, MD

There is renewed emphasis on patient-physician interaction. The relationship between patient-physician communication quality and patient outcome is important, and physician-patient relationship affects patient satisfaction scores. Evidence-based literature exists on ways to improve the quality of patient-physician communication.  This webinar is designed to help surgeons to strategically improve this essential skill.

Upon completion of this webinar, you should be able to:

  •  Understand the relationship between patient experience and patient outcomes
  •  Describe the role of patient-physician communication and patient satisfaction scores.
  •  Describe a communications curriculum and ways to implement aspects into your   practice/institution

All identified conflicts of interest have been resolved:
James Merlino, MD, Press Ganey Associates: Salary, Employment
 

The following have no relevant financial relationships to disclose:
Jennifer S. Beaty, MD, FACS, FASCRS
William C. Cirocco, MD


Management of Metastatic Colon Cancer

Original Webinar Date: September 20, 2018

Moderator: Stephen Sentovich, MD
Speakers: Paula Denoya, MD, FACS, FASCRS; Jonathan Efron, MD, FACS, FASCRS 

Get the webinar recording.
Please log in to your member account before clicking this link. 

This is a webinar on the management of metastatic colon cancer. During the webinar, the following topics will be addressed: how to identify patients with metastatic colon cancer, how to work-up patients with metastatic colon cancer, what nonsurgical and surgical treatments are available and when they are indicated, and what are the expected results of treatment.

Upon completion of this webinar, participants should be able to:

  • Explain the work-up for patients with metastatic colon cancer.
  • Recognize the treatment options for patients with metastatic colon cancer.
  • Describe the follow-up of patients with metastatic colon cancer.

All identified conflicts of interest have been resolved.

Jonathan Efron, MD, FACS, FASCRS: Ethicon Endosurgery: Educational Consultant, Honorarium, Teaching

The following have no relevant financial relationships to disclose:
Paula Denoya, MD, FACS, FASCRS
Stephen Sentovich, MD


Management of Anal Dysplasia: Is There a Correct Approach?

Original webinar date: June 21, 2018

Moderator: Bard C. Cosman, MD, MPH
Speakers: Stephen E. Goldstone, MD, FACS and Emily Steinhagen, MD

Get the webinar recording.
Please log in to your member account before clicking this link.

This webinar will review current strategies for the evaluation and management of the patient with high-grade anal dysplasia (HSIL) in different clinical settings, such as when it is discovered incidentally by the surgeon and when the patient with known HSIL is referred to the surgeon. The role of surgical treatment in the management of “Bowen’s disease” has evolved over the past 25 years, with significant changes in our understanding of this condition, and consequent changes and controversies about the timing and choice of interventions.

When HSIL diagnosis became common, surgeons questioned and largely rejected the practice of wide local excision. Some adapted supravital staining and colposcopy from gynecologic usage, in the now widespread practice of high-resolution anoscopy. Others questioned the cervical-dysplasia model and advocated expectant management of HSIL.  The natural history of HSIL and its conversion or progression to anal cancer stand at the heart of the controversy; differing views on these matters will be reviewed and debated during this webinar. The minimum standard of care which applies to all surgeons, regardless of their position in the controversy, will be discussed.

Upon completion of this webinar, participants should be able to:

  • Identify groups of patients at high risk for high-grade dysplasia (HSIL).
  • Identify other lesions associated with HSIL.
  • Identify arguments for ablation of HSIL.
  • Identify arguments for expectant management of HSIL.
  • Identify the standard of care demands of a surgeon seeing a patient with HSIL identified on Pap smear or biopsy.

All identified conflicts of interest have been resolved.

Stephen E. Goldstone, MD, FACS: Merck and Co.: Honorarium, Consulting Fee, Speaking, Advisory Committee; Medtronic: Honorarium, Consulting Fee, Research Support, Consulting, Speaking, Teaching, Research Protocol; Antiva: Research Support; Inovio: Research Support

The following have no relevant financial relationships to disclose:

Bard C. Cosman, MD, MPH
Emily Steinhagen, MD


Surgical Site Infection

Original webinar date: Thursday, February 15, 2018

Moderated by: Christopher Mantyh, MD
Speakers: ‚ÄčI. Emre Gorgun, MD, and Najjia Mahmoud, MD

Get the webinar recording.
Please log in to your member account before clicking this link.

This webinar examined the significant problem of Surgical Site Infection (SSI) in colorectal surgery and discussed how to measure the rate, as well as efforts to methods to reduce the SSI rate. The use of bundles, the importance of a multidisciplinary team, and financial benefits (and potential penalties) were also discussed. 

Upon completion of this program, participants should be able to:

  • Recognize the magnitude of surgical site infection in colorectal surgery.
  • Identify how to measure and track SSIs.
  • Fix SSI problems in colorectal surgery.
  • Identify the biggest barriers in fixing SSIs in colorectal surgery.

All identified conflicts of interest have been resolved.

Dr. Christopher Mantyh: Becton Dickinson: Honorarium, Consulting, Speaking, Advisory Committee

Dr. I. Emre Gorgun: Boston Scientific: Consulting Fee, Consulting

The following have no relevant financial relationships to disclose:
Dr. Najjia Mahmoud